AstraZeneca, Oxford start work on Omicron-specific COVID vaccine
For this year the company, located in Cambridge revenue will be around 35.82 billion GBp. This is according to the average of the analysts' estimates. This is hugely more than 2021's revenue of 26.62 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2021
The analysts expect for 2021 a net profit of 7.04 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 515 GBp. The price-earnings-ratio equals 16.72.
Huge dividend Astrazeneca
Analysts expect a dividend of 282 GBp per share. Thus the dividend yield equals 3.27 percent. The average dividend yield of the pharmaceutical companies is a limited 1.37 percent.Based on the current number of shares Astrazeneca 's market capitalization equals 11298.82 billion GBp. 23
At 10.23 the stock trades 0.95 percent higher at 8611 GBp.Historical stock prices Astrazeneca2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
